PFAS in Semiconductor Manufacturing: Why “Forever Chemicals” Are Becoming a Strategic Challenge

In today’s pharma and biotech industries, choosing the right R&D partner is a strategic decision that can shape the trajectory of your entire program. Beyond credentials and case studies, the real differentiator lies in how a partner thinks, collaborates, and evolves. Here's four key questions every leader should ask before hiring a R&D partner.

Special Forces operate at peak intensity for decades—but that performance comes with a cumulative physical and psychological cost. Explore how chronic pain, injury, and allostatic load impact long-term readiness, and why early, integrated, whole-system interventions are essential to sustaining performance, extending careers and improving post-service quality of life.

On May 14 and 15, 2026, Battelle co-sponsored "Beyond Forever: Bridging Policy and Industry with PFAS Solutions," convening policymakers and industry experts at Capitol Hill. We sat down with Battelle's Amy Dindal and Jeff Rose to unpack this important conversation about PFAS policy and solutions.

Poor and interrupted sleep is simply a reality of SOF life.That’s why sleep is increasingly recognized within SOF not as a wellness issue, but as a readiness variable that the force must treat. The question is how we apply what the research already tells us, at scale, across the force.

New Approach Methodologies (NAMs) are poised to transform preclinical research and toxicology. Right now there are three interconnected barriers to in vitro NAMs adoption. Moving NAMs into the mainstream will require approaches that tackle all three together.